Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies disclosed on 03-11-2026 that as at 02-11-2026 it holds 25,910,722 cash-settled derivatives in Mitie Group plc 2.5p ordinary shares, representing 1.99% of the share capital, with 0 directly owned shares, 0 stock-settled derivatives and 0 subscription rights; disclosed equity-swap dealings show multiple small increases and decreases of long and short positions at prices between 209.40p and 210.20p per share, and no indemnities or arrangements affecting voting or future acquisition were reported.

Disclaimer*

Companies

Mitie Group (MTO)
UK 100

Latest directors dealings